Covered recipient · General Payments record
GENEVIEVE MATTHEWS
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,729.48
- Reported across 98 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $355.88 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $179.93 | 8 |
| GlaxoSmithKline, LLC. | $53.63 | 3 |
| Novo Nordisk AS | $46.96 | 3 |
| Lilly USA, LLC | $16.42 | 1 |
| Amgen Inc. | $15.39 | 1 |
| Phathom Pharmaceuticals, Inc. | $15.33 | 1 |
| PFIZER INC. | $14.48 | 1 |
| Moderna TX, Inc. | $13.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $29.54 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104985803 | CMS |
| ABBVIE INC. | $32.52 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104985805 | CMS |
| ABBVIE INC. | $17.89 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104985807 | CMS |
| ABBVIE INC. | $9.34 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104985809 | CMS |
| ABBVIE INC. | $26.15 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104985811 | CMS |
| ABBVIE INC. | $27.59 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104985813 | CMS |
| ABBVIE INC. | $29.29 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104985815 | CMS |
| ABBVIE INC. | $7.61 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104985817 | CMS |
| Amgen Inc. | $15.39 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117321416 | CMS |
| GlaxoSmithKline, LLC. | $17.82 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116489244 | CMS |
| GlaxoSmithKline, LLC. | $20.35 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116236768 | CMS |
| GlaxoSmithKline, LLC. | $15.46 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116639628 | CMS |
| Lilly USA, LLC | $16.42 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134984292 | CMS |
| ModernaTX, Inc. | $13.74 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152558476 | CMS |
| Novo Nordisk Inc | $16.65 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096578919 | CMS |
| Novo Nordisk Inc | $16.73 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096688371 | CMS |
| Novo Nordisk Inc | $13.58 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097121075 | CMS |
| PFIZER INC. | $14.48 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131458322 | CMS |
| Phathom Pharmaceuticals, Inc. | $15.33 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151094443 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.